tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

SAVA Stock Latest News

Cassava Sciences Advances Simufilam for Epilepsy Treatment
Company AnnouncementsCassava Sciences Advances Simufilam for Epilepsy Treatment
19d ago
SAVA
Cassava Sciences reports Q2 EPS (92c) vs 13c last year
PremiumThe Fly
Cassava Sciences reports Q2 EPS (92c) vs 13c last year
23d ago
SAVA
Cassava Sciences appoints Hulihan as Chief Medical Officer
PremiumThe Fly
Cassava Sciences appoints Hulihan as Chief Medical Officer
1M ago
SAVA
Cassava Sciences Announces Positive Preclinical Results
PremiumCompany Announcements
Cassava Sciences Announces Positive Preclinical Results
1M ago
8K
SAVA
Cassava reports preclinical study on simufilam for TSC-related epilepsy
PremiumThe Fly
Cassava reports preclinical study on simufilam for TSC-related epilepsy
1M ago
SAVA
Cassava Sciences Reveals Promising Simufilam Preclinical Data
PremiumCompany AnnouncementsCassava Sciences Reveals Promising Simufilam Preclinical Data
2M ago
8K
SAVA
Cassava Sciences presents poster at TSC 2025 on Simufilam
Premium
The Fly
Cassava Sciences presents poster at TSC 2025 on Simufilam
2M ago
SAVA
Cassava Sciences Holds 2025 Annual Meeting, Elects Directors
Premium
Company Announcements
Cassava Sciences Holds 2025 Annual Meeting, Elects Directors
3M ago
8K
SAVA
Cassava Sciences Shifts Focus to TSC-Related Epilepsy
PremiumCompany Announcements
Cassava Sciences Shifts Focus to TSC-Related Epilepsy
4M ago
SAVA
Cassava Sciences reports Q1 EPS (48c) vs (43c) last year
PremiumThe Fly
Cassava Sciences reports Q1 EPS (48c) vs (43c) last year
4M ago
SAVA
Cassava Sciences appoints Bordey as SVP, Neuroscience
PremiumThe Fly
Cassava Sciences appoints Bordey as SVP, Neuroscience
4M ago
SAVA
Cassava Sciences Announces Leadership Changes Amid Strategic Shift
PremiumCompany Announcements
Cassava Sciences Announces Leadership Changes Amid Strategic Shift
5M ago
8K
SAVA
Cassava Sciences chief medical officer James Kupiec to retire
PremiumThe FlyCassava Sciences chief medical officer James Kupiec to retire
5M ago
SAVA
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
PTN
SNY
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
ALLR
ALNY
Cassava Sciences announces Phase 3 REFOCUS-ALZ did not meet primary endpoint
PremiumThe Fly
Cassava Sciences announces Phase 3 REFOCUS-ALZ did not meet primary endpoint
6M ago
SAVA
Cassava Sciences to resume trading at 8:35 am ET
PremiumThe Fly
Cassava Sciences to resume trading at 8:35 am ET
6M ago
SAVA
Cassava Sciences to discontinue all efforts to develop simufilam in Alzheimer’s
PremiumThe Fly
Cassava Sciences to discontinue all efforts to develop simufilam in Alzheimer’s
6M ago
SAVA
Cassava Sciences down 12% after simufilam doesn’t hit Alzheimer’s trial endpoint
PremiumThe Fly
Cassava Sciences down 12% after simufilam doesn’t hit Alzheimer’s trial endpoint
6M ago
SAVA
Morning Movers: Mobileye jumps following Volkswagen ADAS partnership
PremiumThe FlyMorning Movers: Mobileye jumps following Volkswagen ADAS partnership
6M ago
CNM
DJT
H.C. Wainwright reiterates Neutral, $2 target on Cassava after AD trial data
Premium
The Fly
H.C. Wainwright reiterates Neutral, $2 target on Cassava after AD trial data
6M ago
SAVA
Cassava Sciences’ Alzheimer’s Drug Trials Fall Short, Neutral Rating Maintained Amid Uncertainties
Premium
Ratings
Cassava Sciences’ Alzheimer’s Drug Trials Fall Short, Neutral Rating Maintained Amid Uncertainties
6M ago
SAVA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >